Sort
85,873 grants matching “alzheimers”
Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
$1,182,906Joel H Kramer · University Of California, San Francisco · UH3 · FY2018 · NS
Systems Approach to Unraveling the Genetic Basis of Heart Failure
$1,182,797James N Weiss · University Of California Los Angeles · R01 · FY2014 · HL
Epigenomic mapping approaches for cell-type classification in the brain
$1,182,666Joseph R Ecker · Salk Institute For Biological Studies · U01 · FY2014 · MH
Open Drug Discovery Center for Alzheimer's Disease
$1,182,389Allan I Levey · Emory University · U54 · FY2022 · AG
Novel mechanisms of NSAID action in Alzheimer disease
$1,182,362University Of California San Diego · P01 · FY2004 · AG
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
$1,182,309Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2024 · AG
Identification of protective factors for cognitive resilience in adults with Down Syndrome: A multi-omic study
$1,182,026Joseph Hyungwoo Lee · Columbia University Health Sciences · R56 · FY2018 · AG
Genomic Convergence in Alzheimer Disease
$1,181,897Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2010 · AG
Establish a Public Private Partnership for COVID19 Research
$1,181,709David N. Wholley · Foundation For The Nih · OT2 · FY2023 · OD
Comparative Single-Cell Epigenomic Analysis of AD-like Pathogenesis in Unconventional Animal Models
$1,181,657Xiangmin Xu · University Of California-Irvine · R24 · FY2023 · AG
BDNF Regulation: Roles in Plasticity and Neuroprotection
$1,181,600University Of California Irvine · P01 · FY2003 · NS
Alzheimer's Disease Patient Registry (ADPR)
$1,181,574Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2006 · AG
Phase 1 Trial to Assess Safety and Immune Effects of Xenon Gas in Healthy Human Subjects
$1,181,555Ilya Ilin · General Biophysics, Llc · R42 · FY2024 · AG
Brain and its Vasculature
$1,181,370Marcus E Raichle · Washington University · P50 · FY2009 · NS
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS
$1,181,250Robyn S Klein · Washington University · R35 · FY2022 · NS
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS
$1,181,250Matthew D Cain · Washington University · R35 · FY2023 · NS
Cell Models for AD: Lipids and Related Signaling Pathways
$1,180,907Grace Y Sun · University Of Missouri-Columbia · P01 · FY2010 · AG
Blood amyloid-beta relationship with amyloid plaques and CSF amyloid-beta
$1,180,828Randall J Bateman · Washington University · RF1 · FY2020 · AG
Signaling in the retina and retinal pigment epithelium
$1,180,773Thomas Redmond · National Eye Institute · ZIA · FY2016 · EY
Core E: Imaging Core
$1,180,581Tammie Lee Smith Benzinger · Washington University · P01 · FY2020 · AG
Science in a Culture of Mentoring
$1,179,870Judith A James · Oklahoma Medical Research Foundation · P30 · FY2012 · GM
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence
$1,179,683A Eden Evins · Massachusetts General Hospital · R01 · FY2014 · DA
A Pragmatic Crossover Trial to Test the Effectiveness of a Novel Lighting System to Reduce Nighttime Falls in Persons with Alzheimerâs Disease and Related Dementias
$1,179,423Sheryl Zimmerman · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AG
Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease
$1,179,037Joel H Kramer · University Of California, San Francisco · UH3 · FY2020 · NS
The regulation of synaptic transmission and neural circuit function
$1,178,813Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS